1417528-38-1

Basic information

• Product Name: (4-(4-bromobenzyl)-5-mercapto-4H-1,2,4-triazol-3-yl)methanol
• Synonyms: (4-(4-bromobenzyl)-5-mercapto-4H-1,2,4-triazol-3-yl)methanol
• CAS NO: 1417528-38-1
• Molecular Weight: 300.179
• Mol File: 1417528-38-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: (4-(4-bromobenzyl)-5-mercapto-4H-1,2,4-triazol-3-yl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (4-(4-bromobenzyl)-5-mercapto-4H-1,2,4-triazol-3-yl)methanol(1417528-38-1)
• EPA Substance Registry System: (4-(4-bromobenzyl)-5-mercapto-4H-1,2,4-triazol-3-yl)methanol(1417528-38-1)

Safety Data

• Hazardous Substances Data: 1417528-38-1(Hazardous Substances Data)

Upstream product

• 3959-07-7 4-Bromobenzylamine 
• 2076-56-4 4-bromobenzyl isothiocyanate 
• 3530-14-1 hydroxyacetylhydrazine 

Downstream Products

• 1417528-40-5 (4-(4-bromobenzyl)-4H-1,2,4-triazol-3-yl)methanol 
• 1417528-85-8 2-thioxo-1-((4-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)-4H-1,2,4-triazol-3-yl)methyl)-2,3,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417528-87-0 1-((5-(hydroxymethyl)-4-((4’-(trifluoromethyl)biphenyl-4-yl)methyl)-4H-1,2,4-triazol-3-yl)methyl)-2-thioxo-2,3,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417527-46-8 2-(4-fluorobenzylthio)-1-((5-(hydroxymethyl)-4-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)-4H-1,2,4-triazol-3-yl)methyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417527-48-0 5-((2-(4-fluorobenzylthio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)methyl)-4-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)-4H-1,2,4-triazole-3-carbaldehyde 
• 1417527-47-9 2-(4-fluorobenzylthio)-1-((4-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)-4H-1,2,4-triazol-3-yl)methyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417528-14-3 2-(4-fluorobenzylthio)-1-((5-(1-hydroxyethyl)-4-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)-4H-1,2,4-triazol-3-yl)methyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417527-49-1 1-((5-((dimethylamino)methyl)-4-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)-4H-1,2,4-triazol-3-yl)methyl)-2-(4-fluorobenzylthio)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417527-53-7 1-((5-((diethylamino)methyl)-4-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)-4H-1,2,4-triazol-3-yl)methyl)-2-(4-fluorobenzylthio)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417527-58-2 2-(4-fluorobenzylthio)-1-((5-((isopropyl(methyl)amino)methyl)-4-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)-4H-1,2,4-triazol-3-yl)methyl)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417527-88-8 1-((5-((cyclopropyl(methyl)amino)methyl)-4-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)-4H-1,2,4-triazol-3-yl)methyl)-2-(4-fluorobenzylthio)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417527-62-8 1-((5-((4-ethylpiperazin-1-yl)methyl)-4-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)-4H-1,2,4-triazol-3-yl)methyl)-2-(4-fluorobenzylthio)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417527-60-6 1-((5-(((2S,6R)-2,6-dimethylmorpholino)methyl)-4-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)-4H-1,2,4-triazol-3-yl)methyl)-2-(4-fluorobenzylthio)-6,7-dihydro-1H-cyclopenta[d]pyrimidin-4(5H)-one 
• 1417527-92-4 1-((5-((4-(dimethylamino)piperidin-1-yl)methyl)-4-((4’-(trifluoromethyl)biphenyl-4-yl)methyl)-4H-1,2,4-triazol-3-yl)methyl)-2-(4-fluorobenzylthio)-6,7-dihydro-1-cyclopenta[d]pyrimidin-4(5H)-one 

Relevant articles and documents

AZOLE HETEROCYCLIC COMPOUND, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE

The present invention relates to the filed of pharmarcutical chemistry, and in particular, to a novel class of azole compounds represented by general formula (I), (II) or (III) amd a preparation method thereof, a pharmarcutical composition with the compounds as active components, and a use of the azole compounds and the pharmarcutical composition in the preparation of a medicament for treatment of diseases associated with Lp-PLA2 enzyme activities, wherein each substituent is as deinfed in the specifictaion.

Design and synthesis of imidazole and triazole derivatives as Lp-PLA 2 inhibitors and the unexpected discovery of highly potent quaternary ammonium salts

New Lp-PLA2 inhibitors were synthesized by the bioisosteric replacement of the amide group of Darapladib with an imidazole or a triazole. Unfortunately, the inhibitory activities of these derivatives were lower than that of Darapladib. But interestingly, a series of quaternary ammonium salts that were isolated as by-products during this synthetic work were found with high potency. Of these by-products, compound 22c showed a similar profile to Darapladib both in vitro and in vivo.